Search clinical trials for: Serotonin Antagonists

Total 35178 results

Genuine Research Center, Egypt
P&C Labs, Egypt

Completed

Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)

Healthy

Egypt
Martha Sajatovic
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)

Bipolar Disorder | Medication Adherence | Medication Non Adherence

United States
Children's Hospital of Fudan University

Withdrawn

Clinical Efficacy and Change of Life Quality Through Using the Comprehensive Behavioral Intervention Treatment for Tics

Tic Disorders
Alkermes, Inc.

Completed

A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Schizophrenia

United States, Canada
Serge Beaulieu
Bristol-Myers Squibb

Terminated

Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study

Bipolar Disorder | Depressive Episode

Canada
San Francisco Department of Public Health
National Institute on Drug Abuse (NIDA)

Completed

Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals

HIV Infections | Substance Abuse

United States
Bristol-Myers Squibb
Otsuka America Pharmaceutical

Completed

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Janssen Research & Development, LLC

Completed

An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia

Schizophrenia

Ukraine, United States, Spain, India, Romania, Russian Federation, Slovakia
Si Tianmei

Unknown

A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders

Sexual Dysfunction | Hyperprolactinemia

China
Universita di Verona

Unknown

Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia (CHAT)

Schizophrenia

Italy
Seoul National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia

Schizophrenia

Korea, Republic of
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia

Schizophrenia

United States
University of Texas Southwestern Medical Center

Completed

Aripiprazole for Bipolar Disorder and Alcohol Use Disorder

Alcoholism | Bipolar Disorder | Alcohol Abuse

United States
Shanghai Mental Health Center

Withdrawn

Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder
Otsuka Beijing Research Institute

Completed

Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia

Schizophrenia

China
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

Bipolar I Disorder

United States, Taiwan, Romania, Korea, Republic of, Japan, Poland, Canada
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole

Nervous System Diseases | Schizophrenia | Mental Disorder

United States
H. Lundbeck A/S
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole Once-monthly in Patients With Schizophrenia

Schizophrenia

United States
CMG Pharmaceutical Co. Ltd

Completed

Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers

Schizophrenia
US Department of Veterans Affairs

Withdrawn

Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial

Methamphetamine Dependence
Wei Hao

Terminated

An Study of Aripiprazole in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

China
Otsuka Pharmaceutical Development & Commercialization...
Covance

Completed

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia (ASPIRE)

Schizophrenia

Spain, Korea, Republic of, United States, Russian Federation, Chile, Estonia, Finland, Mexico, Hungary, Bulgaria, Croatia, Serbia, France, Poland, Romania, Thailand, Puerto Rico, Slovakia, Taiwan, Australia, India, Argentina, South... and more
Duke University
Bristol-Myers Squibb

Completed

Metabolic Signatures and Biomarkers in Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

Schizophrenia

United States
North Suffolk Mental Health Association
Eli Lilly and Company

Completed

A Placebo-Controlled, Cross-Over Trial of Aripiprazole

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

Psychotic Disorders | Schizophrenia
Taichung Veterans General Hospital

Unknown

Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine (HeartAriQue)

Schizophrenia | Bipolar

Taiwan
Englewood Hospital and Medical Center

Enrolling by invitation

Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients With Advanced Stage Cancer

Anorexia Nervosa With Significantly Low Body Weight

United States
Linkoeping University

Completed

Serum Concentrations of Antidepressant Drugs in Pregnant Women - a Naturalistic Study (PAPA)

Pregnancy | Pharmacokinetics | Antidepressive Agents

Sweden
Ain Shams University

Completed

Emergence Agitation After Nasal Surgery: a Randomized Controlled Comparison Between Melatonin and Mirtazapine

Agitation

Egypt
Sun Yat-sen University

Unknown

Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression

Depression | Carcinoma, Non-Small-Cell Lung

China
Seoul National University Boramae Hospital

Terminated

Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C

Depression

Korea, Republic of
Universiti Sains Malaysia
Yale University

Unknown

Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia

Heroin Dependence | Amphetamine Dependence

Malaysia
Janssen Research & Development, LLC

Completed

Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy Participants (DRiVESaFe)

Healthy

Netherlands
Rush University Medical Center
ElMindA Ltd; Takeda Pharmaceuticals North America, Inc.

Completed

The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder

Major Depressive Disorder

United States
H. Lundbeck A/S

Completed

Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD) (RECONNECT)

Anxiety Disorders | MDD

Estonia, France, Italy, Korea, Republic of, Poland, Spain
University of Miami
Takeda; Emory University

Completed

Vortioxetine for Posttraumatic Stress Disorder

Post-Traumatic Stress Disorder

United States
Takeda

Completed

Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder

Major Depressive Disorder

United States
Lundbeck Canada Inc.

Completed

Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine (AtWoRC)

Major Depressive Disorder

Canada
H. Lundbeck A/S

Completed

Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder

Depressive Disorder | Anxiety Disorder

United States, Germany
Takeda

Completed

Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic Impairment

Severe Hepatic Impairment

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States, Spain, Hungary, South Africa, Croatia, France, Poland, India, Canada, Sweden, Malaysia
Capital Medical University

Completed

The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial

Major Depressive Disorder

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia

Schizophrenia

China
IRCCS San Raffaele Roma

Recruiting

Tolerability, Safety and Efficacy of Vortioxetine (VorDe-PD)

Depression

Italy
Todd Doyle
Takeda

Withdrawn

Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes

Major Depressive Disorder | Type2 Diabetes

United States
H. Lundbeck A/S
ICON plc

Completed

Vortioxetine in Patients With Depression and Early Dementia (MEMORY)

Dementia | Major Depressive Disorder

Korea, Republic of, Spain, Poland, Estonia, France, Italy
H. Lundbeck A/S

Completed

Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India

Major Depressive Disorder

India
H. Lundbeck A/S

Completed

Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age

Depressive Disorder, Major

Spain, Hungary, Russian Federation, Bulgaria, Estonia, France, Germany, Italy, Latvia, Poland, Serbia, South Africa, United Kingdom

3

Subscribe